Tuesday, 6 December 2022
Our 3 February webinar - Tafenoquine: are higher doses needed for P. Vivax?
New research using WWARN-hosted clinical trial data on tafenoquine, a newly licensed antimalarial drug for radical cure of Plasmodium vivax malaria, finds that higher doses are needed to cure infection. Join our expert discussion on whether we are getting the dosing right.
Monday, 28 November 2022
Meta-analysis informed the updated WHO guidelines for treatment of uncomplicated malaria in the first trimester of pregnancy
A new WWARN meta-analysis commissioned by the World Health Organization (WHO) which informed a change to its treatment guidelines* has been published in The Lancet. The study provides compelling evidence that artemether-lumefantrine should now replace quinine as the treatment of choice in the first ...
Wednesday, 16 November 2022
Tribute to Professor Mamadou Pathé Diallo
It is with great sadness that IDDO has learnt of the passing of Professor Mamadou Pathé Diallo, a valued member of the IDDO team since 2019. Professor Diallo had been a Professor of Paediatrics since 1988 and was the Head of the Medical Centre & Health Counselling (CEMECO) in Kipé, the Paediatric, H...
Monday, 24 October 2022
IDDO attending ASTMH
Come and meet us at this year’s ASTMH 71st Annual Meeting - the first fully in-person meeting since 2019. Thousands of delegates are expected to attend with leading global health researchers from more than 111 countries around the world. During the conference we have several posters, talks, meetings...
Wednesday, 5 October 2022
IDDO and WWARN’s Director discussing malaria and resistance at RSTMH Annual Meeting
Join IDDO and WWARN Director, Professor Philippe Guérin at this year’s RSTMH’s Annual Meeting where he will be discussing topical issues in malaria and in resistance with a wide range of speakers and panellists.
Friday, 23 September 2022
A new WWARN study supports safety of WHO recommended malaria treatment to advance elimination and reduce spread of artemisinin resistance
A new WWARN study, published in BMC Medicine, supports a World Health Organization (WHO) recommendation that a single primaquine target dose of 0.25 mg/kg is generally safe and well tolerated when given together with an ACT to treat malaria.
Friday, 23 September 2022
Routine surveillance data can provide an early warning system for antimalarial resistance in pre-elimination areas in Africa
In the first published study of its kind, a new WWARN paper in the Malaria Journal has created near-real-time maps to support antimalarial drug resistance monitoring, using routine malaria surveillance data and individually patient linked data on molecular markers of antimalarial drug resistance.
Wednesday, 21 September 2022
New studies alert to the risk of poor-quality human antibiotics and veterinary antimicrobials
New studies suggest that substandard and falsified (SF) antimicrobials, in particular antibiotics, are widely spread with higher prevalence in low-and middle-income countries (LMIC). The quality of the evidence available in the scientific literature is poor but the issue has significant risks for On...
Thursday, 4 August 2022
FORESFA and VIE project meetings
The Medicine Quality Research Group organised a multidisciplinary hybrid meeting at Keble College, Oxford, July 3 to 6, for the FORESFA project ‘Forensic epidemiology and impact of substandard and falsified antimicrobials on public health’, funded by a Wellcome Collaborative Award.
Wednesday, 20 July 2022
Incomplete reporting of COVID-19 disease severity criteria compromises meta-analysis
Patients affected by COVID-19 should be treated according to the severity of their disease. However, new research out today finds that not all key national or international organisations define severity in the same way.
Thursday, 23 June 2022
Field evaluation of EasyScan GO: a digital malaria microscopy device
Microscopic examination of Giemsa-stained blood films is key to quantifying and detecting malaria parasites but there can be difficulties in ensuring both a high-quality manual reading and inter-reader reliability. The EasyScan GO was developed as a potential solution to this, a microscopy device us...
Friday, 6 May 2022
Experts emphasise the importance of cooperation in sharing data on artemisinin resistance in Africa
Drug-resistant malaria is now a critical public health emergency on a global scale. In a new editorial a diverse group of malaria researchers, including WWARN senior scientists, have highlighted that the artemisinin confirmed recently in Rwanda and Uganda is likely just the ‘tip of the spear’, with ...